hrp0097p2-188 | Adrenals and HPA Axis | ESPE2023

7-year-old girl as compound heterozygote of non-classic congenital adrenal hyperplasia

Bali Maria , Sotiriou Spyridoula , Magoula Marousa , Kalamara Panagiota , Papafotiou Chrysanthe , Papagiannidi Marina , Ioannidou Gerina

Background: Deficiency of 21-hydroxylase (CYP21A2) is responsible of 90-95% of all cases of congenital adrenal hyperplasia (CAH). CYP21A2 converts 17OHprogesterone into 11deoxycortisol and is encoded by the CYP21A2 gene on chromosome 6p21.3, within the class III region of the highly polymorphic HLA histocompatibility complex. CAH refers to a group of autosomal recessive disorders. Nonclassic CAH (NCAH) is milder and more common, however it may not be identifie...

hrp0097p2-216 | Adrenals and HPA Axis | ESPE2023

Non classic congenital adrenal hyperplasia caused by mutations in CYP21A2

Magoula Marousa , Sotiriou Spyridoula , Bali Maria , Kalamara Panagiota , Papafotiou Chrysanthe , Papagiannidi Marina , Ioannidou Gerina

Background: Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive genetic defects in cortisol synthesis caused by the deficiency of 21-hydroxylase which convert 17-hydroxyprogesterone to 11-deoxycortisol. A variety of mutations in one or more genes encoding enzymes essential for cortisol synthesis leads to a spectrum of disorders and disease severity. In general, complete or nearly complete enzymatic defects result in overt adrenal insufficien...